U.S. Customs and Border Protection February 5, 2018 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Notice of Issuance of Final Determinations Concerning Certain Pharmaceutical Products
This document provides notice that U.S. Customs and Border Protection (``CBP'') has issued 11 final determinations concerning the country of origin of certain pharmaceutical products. Based upon the facts presented, CBP has concluded that the country of origin of the Rosuvastatin Calcium Tablets, Levofloxacin Tablets, Levetiracetam Tablets, Metoprolol Tartrate Tablets, Gabapentin Capsules, Carvedilol Tablets, Paroxetine Hydrochloride Tablets, Entecavir Tablets, Montelukast Sodium Tablets, Simvastatin Tablets, Donepezil Hydrochloride Tablets is India for purposes of U.S. Government procurement.
Notice of Issuance of Final Determination Concerning Certain Ethernet Switch Products
This document provides notice that U.S. Customs and Border Protection (``CBP'') has issued a final determination concerning the country of origin of certain ethernet switch products known as Nyquist Ethernet Switches. Based upon the facts presented, CBP has concluded that the country of origin of the Nyquist Ethernet Switches is Mexico for purposes of U.S. Government procurement.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
